Back to Journals » ImmunoTargets and Therapy

ImmunoTargets and Therapy

ISSN: 2253-1556

Editor-in-Chief: Professor Michael R Shurin

ImmunoTargets and Therapy is an international journal that aims to present and publish basic and clinical research on the aspects of immunology in health and disease. ImmunoTargets and Therapy is primarily focused on the immunological basis of disease and explores the evidence behind new and existing immunotherapies in terms of improving outcomes and, importantly, will seek to define their usage in terms of ultimate uptake and acceptance by the patient and health care professional.

This journal is a member of and subscribes to the principles of the Committee on Publication Ethics (COPE). 

Latest articles:

- 5 records -

Immunotargets and Therapy for Prurigo Nodularis

Labib A, Ju T, Vander Does A, Yosipovitch G

ImmunoTargets and Therapy 2022, 11:11-21

Published Date: 26 April 2022

Immune Checkpoint Blockade for the Treatment of Hodgkin Lymphoma

Lin AY, Schnitter JM, Gordon LI

ImmunoTargets and Therapy 2022, 11:1-10

Published Date: 23 February 2022

Pathophysiology of Non-IgE-Mediated Food Allergy

Zhang S, Sicherer S, Berin MC, Agyemang A

ImmunoTargets and Therapy 2021, 10:431-446

Published Date: 29 December 2021

Understanding and Managing Severe Asthma in the Context of COVID-19

Kong-Cardoso B, Ribeiro A, Aguiar R, Pité H, Morais-Almeida M

ImmunoTargets and Therapy 2021, 10:419-430

Published Date: 11 December 2021


Read more articles